Edible fungal polysaccharides, the gut microbiota, and host health

Carbohydr Polym. 2021 Dec 1:273:118558. doi: 10.1016/j.carbpol.2021.118558. Epub 2021 Aug 14.

Abstract

The plasticity of the gut microbiota (GM) creates an opportunity to reshape the biological output of gut microbes by manipulating external factors. It is well known that edible fungal polysaccharides (EFPs) can reach the distal intestine and be assimilated to reshape the GM. The GM has unique devices that utilize various EFPs and produce oligosaccharides, which can selectively promote the growth of beneficial bacteria and are fermented into short-chain fatty acids that interact closely with intestinal cells. Here we review EFPs-based interventions for the GM, particularly the key microorganisms, functions, and metabolites. In addition, we discuss the bi-directional causality between GM imbalance and diseases, and the beneficial effects of EFPs on host health via GM. This review can offer a valuable reference for the design of edible fungal polysaccharide- or oligosaccharide-based nutrition interventions or drug development for maintaining human health by targeted regulation of the GM.

Keywords: Edible fungal polysaccharides; Gut microbiota; Inflammatory bowel disease; Metabolic disorder; Short chain fatty acids; Tumour.

Publication types

  • Review

MeSH terms

  • Animals
  • Bacteria / drug effects
  • Fatty Acids, Volatile / metabolism
  • Fungal Polysaccharides / metabolism
  • Fungal Polysaccharides / therapeutic use*
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / physiology
  • Humans
  • Prebiotics

Substances

  • Fatty Acids, Volatile
  • Fungal Polysaccharides
  • Prebiotics